Masimo (MASI) - Stock Price & Dividends

Masimo Corporation is a global leader in developing, manufacturing, and selling advanced patient monitoring technologies and automation solutions. One of its notable offerings is the Masimo Signal Extraction Technology (SET) pulse oximetry, which tackles the limitations of traditional pulse oximetry by offering precise measurements even in challenging conditions like motion and low perfusion. In addition to this, Masimo's Rainbow SET platform provides a range of noninvasive monitoring capabilities, such as tracking carboxyhemoglobin, methemoglobin, pleth variability index, and more.

Moreover, Masimo Corporation also specializes in providing solutions for brain function monitoring, patient tracking, and activity monitoring, along with products in neuromodulation and hospital automation. Their Hospital Automation platform comprises various solutions like Patient SafetyNet, SedLine brain function monitoring, NomoLine capnography, and O3 regional oximetry, offering comprehensive support to healthcare providers across different settings.

With a wide distribution network encompassing direct sales, distributor partnerships, and collaborations with original equipment manufacturers, Masimo's products reach a vast clientele ranging from hospitals and emergency services to physician offices, long-term care facilities, and even consumers. Additionally, Masimo caters to individual wellness needs through e-commerce platforms like masimopersonalhealth.com, amazon.com, and shopify.com.

Established in 1989 and headquartered in Irvine, California, Masimo Corporation continues to drive innovation in the healthcare industry, empowering healthcare practitioners with cutting-edge technologies to enhance patient care and outcomes. For more information, you can visit their website at https://www.masimo.com.